These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8578189)

  • 1. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).
    Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W
    Scand J Gastroenterol; 1995 Sep; 30(9):892-6. PubMed ID: 8578189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
    Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
    Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion.
    Fukase N; Takahashi H; Manaka H; Igarashi M; Yamatani K; Daimon M; Sugiyama K; Tominaga M; Sasaki H
    Diabetes Res Clin Pract; 1992 Mar; 15(3):187-95. PubMed ID: 1576919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.
    Ranganath L; Norris F; Morgan L; Wright J; Marks V
    Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum.
    Herrmann-Rinke C; Hörsch D; McGregor GP; Göke B
    Peptides; 1996; 17(4):571-6. PubMed ID: 8804063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
    Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M
    Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine.
    Mortensen K; Christensen LL; Holst JJ; Orskov C
    Regul Pept; 2003 Jul; 114(2-3):189-96. PubMed ID: 12832109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
    Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
    Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An osmotic stimulus-mediating glucagon-like peptide-1 (7-36 amide) (GLP-1) secretion in acarbose-induced sucrose malabsorption?
    Ranganath L; Morgan L
    Nutrition; 2000 Jan; 16(1):64-5. PubMed ID: 10674237
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides.
    Herrmann-Rinke C; Vöge A; Hess M; Göke B
    J Endocrinol; 1995 Oct; 147(1):25-31. PubMed ID: 7490533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo.
    Madariaga H; Lee PC; Heitlinger LA; Lebenthal E
    Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose.
    Gerard J; Jandrain B; Pirnay F; Pallikarakis N; Krzentowski G; Lacroix M; Mosora F; Luyckx AS; Lefèbvre PJ
    Diabetes; 1986 Nov; 35(11):1294-301. PubMed ID: 3530858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.